Evaluations of rationally designed rift valley fever vaccine candidate RVax-1 in mosquito and rodent models

Keyphrases

• Pregenomic RNA (pgRNA) 100%
• Vaccine Candidate 100%
• Rift Valley Fever 100%
• Rodent Models 100%
• Rift Valley Fever Vaccine 100%
• MP-12 Vaccine 100%
• Rationally Designed 100%
• RVF Virus 100%
• Immunogenicity 50%
• Attenuation 50%
• Live Attenuated 50%
• Mouse Model 50%
• Vaccine Strain 50%
• Viral Genome 50%
• Mosquito-borne 50%
• MP-12 50%
• Rift Valley Fever Virus 50%
• Further Development 50%
• Viral Spread 50%
• Zoonosis 50%
• Protective Efficacy 50%
• Africa 50%
• Single-dose Vaccine 50%
• Endemic Countries 50%
• Infected Mosquitoes 50%
• Ruminants 50%
• Effective Prevention 50%
• Protective Epitope 50%
• Aedes Mosquito 50%
• Arabian Peninsula 50%
• Inbred Mice 50%
• Reassortant Strain 50%

Immunology and Microbiology

• Rift Valley Fever 100%
• Rift Valley Fever Virus 100%
• Immunogenicity 33%
• Wild Type 33%
• Mouse Model 33%
• Reassortment 33%
• Epitope 33%
• Zoonosis 33%
• Aedes aegypti 33%
• Inbred Mouse Strain 33%